Abstract
In this study we investigated the effect of selective (M1) and non-selective (M1 and M2) pharmacologic blockade of muscarinic receptors on cholecystokinin-induced gallbladder emptying. After validating the method of study, the gallbladder function was evaluated in 15 normal volunteers by quantitative biliary scintigraphy, and the effect of intravenous atropine (0.15 mg/10 kg) and pirenzepine (10 mg) was analyzed in each subject. Atropine significantly reduced the ejection period and the ejection fraction of gallbladder evacuation. Pirenzepine reduced the ejection period, but the ejection fraction remained unchanged. We conclude that the effect of cholecystokinin on gallbladder motility is mediated through muscarinic receptors. Our results suggest that M2 receptors, but not M1 receptors, are involved in this response.
Similar content being viewed by others
References
Fisher RS, Rock E, Malmud LS: Cholinergic effect on gallbladder emptying in humans. Gastroenterology 89:716–722, 1985
Gullo L, Bolondi L, Priori P, Casanova P, Labo G: Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man. Digestion 29:209–213, 1984
Marzio L, Digiammarco AM, Neri M, Cuccurullo F, Malfertheiner P: Atropine antagonizes cholecystokinin and cerulein-induced gallbladder evacuation in man: A real ultrasonographic study. Am J Gastroenterol 80:1–4, 1985
Rattan S: M1 and M2 muscarinic receptor subtypes in the lower esophageal sphincter.In Muscarinic Receptor Subtypes in the GI Tract. G Lux, EE Daniel (eds.) Berlin, Springer-Verlag, 1985, pp 43–51
Krishnamurthy GT, Bobba VR, Kingston E: Radionuclide ejection fraction: A technique for quantitative analysis of motor function of the human gallbladder. Gastroenterology 80:482–490, 1981
Conover WJ: Practical Nonparametric Statistics. New York, John Wiley & Sons, 1980
Krishnamurthy GT, Bobba VR, Kingston E, Turner F: Measurement of gallbladder emptying sequentially using a single dose of99mTc-labeled hepatobiliary agent. Gastroenterology 83:773–776, 1982
Krishnamurthy GT, Turner FE, Mangham D, Bobba VR, White SA, Langrell K: Ceruletide intravenous doseresponse study by a simplified scintigraphic technique. AJR 144:733–737, 1985
Thompson JC, Fender R, Ramus NI, Villar HV, Rayford PL: Cholecystokinin metabolism in man and dogs. Ann Surg 182:496–504, 1975
Hong SS, Magee DF, Crewdson F: The physiologic regulation of gallbladder evacuation. Gastroenterology 30:625–630, 1956
Bertaccini G, De Caro G, Endean R, Erspamer V, Impicciatore M: The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gallbladder. Br J Pharmacol 34:291–310, 1968
Yau WM, Makhlouf GM, Edwards LE, Farrar JT: Mode of action of cholecystokinin and related peptides on gallbladder muscle. Gastroenterology 65:451–456, 1973
Takahashi I, Suzuki T, Aizawa I, Itoh Z: Comparison of gallbladder contraction induced by motilin and cholecystokinin in dogs. Gastroenterology 82:419–424, 1982
Strah KM, Pappas TN, Melendez RL, Debas HT: Contrasting cholinergic dependence of pancreatic and gallbladder responses to cholecystokinin. Am J Physiol 250:G665-G669, 1986
Behar J, Biancani P: Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi. Gastroenterology 92:764–770, 1987
Behar J, Biancani P: Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. J Clin Invest 66:1231–1239, 1980
Hammer R, Koss FW: The pharmacokinetic profile of pirenzepine. Scand J Gastroenterol 14(suppl 57):1–6, 1979
Garrigues V, Ponce J, Pertejo V, Sala T, Berenguer J: Effects of atropine and pirenzepine on sphincter of Oddi motility. A manometric study. J Hepatol 3:247–250, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garrigues, V., Ponce, J., Cano, C. et al. Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man. Digest Dis Sci 37, 101–104 (1992). https://doi.org/10.1007/BF01308350
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01308350